SK284461B6 - Imobilizované komplexy antagonistov LHRH so stabilizovanou aktivitou, spôsob ich výroby a liečivo obsahujúce tento komplex - Google Patents

Imobilizované komplexy antagonistov LHRH so stabilizovanou aktivitou, spôsob ich výroby a liečivo obsahujúce tento komplex Download PDF

Info

Publication number
SK284461B6
SK284461B6 SK1316-99A SK131699A SK284461B6 SK 284461 B6 SK284461 B6 SK 284461B6 SK 131699 A SK131699 A SK 131699A SK 284461 B6 SK284461 B6 SK 284461B6
Authority
SK
Slovakia
Prior art keywords
complexes
hormone
cetrorelix
peptide
acid
Prior art date
Application number
SK1316-99A
Other languages
English (en)
Slovak (sk)
Other versions
SK131699A3 (en
Inventor
J�Rgen Engel
Wolfgang Deger
Thomas Reissmann
G�Nter Losse
Wolfgang Naumann
Sandra Murgas
Original Assignee
Zentaris Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zentaris Gmbh filed Critical Zentaris Gmbh
Publication of SK131699A3 publication Critical patent/SK131699A3/sk
Publication of SK284461B6 publication Critical patent/SK284461B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/645—Polycationic or polyanionic oligopeptides, polypeptides or polyamino acids, e.g. polylysine, polyarginine, polyglutamic acid or peptide TAT
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SK1316-99A 1997-03-26 1998-03-11 Imobilizované komplexy antagonistov LHRH so stabilizovanou aktivitou, spôsob ich výroby a liečivo obsahujúce tento komplex SK284461B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19712718A DE19712718C2 (de) 1997-03-26 1997-03-26 Immobilisierte und aktivitätsstabilisierte Komplexe von LHRH-Antagonisten und Verfahren zu deren Herstellung
PCT/EP1998/001398 WO1998042381A1 (de) 1997-03-26 1998-03-11 Immobilisierte und aktivitätsstabilisierte komplexe von lhrh-antagonisten und verfahren zu deren herstellung

Publications (2)

Publication Number Publication Date
SK131699A3 SK131699A3 (en) 2000-05-16
SK284461B6 true SK284461B6 (sk) 2005-04-01

Family

ID=7824698

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1316-99A SK284461B6 (sk) 1997-03-26 1998-03-11 Imobilizované komplexy antagonistov LHRH so stabilizovanou aktivitou, spôsob ich výroby a liečivo obsahujúce tento komplex

Country Status (27)

Country Link
US (2) US6022860A (zh)
EP (1) EP0981377B1 (zh)
JP (1) JP4180120B2 (zh)
CN (1) CN1150943C (zh)
AR (1) AR012186A1 (zh)
AT (1) ATE249245T1 (zh)
AU (1) AU747808B2 (zh)
BR (1) BR9807887B1 (zh)
CA (1) CA2285054C (zh)
CZ (1) CZ300755B6 (zh)
DE (2) DE19712718C2 (zh)
DK (1) DK0981377T3 (zh)
ES (1) ES2206912T3 (zh)
HK (1) HK1025255A1 (zh)
HU (1) HUP0002059A3 (zh)
IL (1) IL131181A (zh)
NO (1) NO327404B1 (zh)
NZ (1) NZ337343A (zh)
PL (1) PL190090B1 (zh)
PT (1) PT981377E (zh)
RU (1) RU2207151C2 (zh)
SK (1) SK284461B6 (zh)
TR (1) TR199902168T2 (zh)
TW (1) TW520288B (zh)
UA (1) UA69381C2 (zh)
WO (1) WO1998042381A1 (zh)
ZA (1) ZA982225B (zh)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6828415B2 (en) * 1993-02-19 2004-12-07 Zentaris Gmbh Oligopeptide lyophilisate, their preparation and use
EP0788799A3 (en) 1996-02-07 1998-10-21 ASTA Medica Aktiengesellschaft LHRH-Antagonists in the treatment of fertility disorders
US20070185032A1 (en) * 1996-12-11 2007-08-09 Praecis Pharmaceuticals, Inc. Pharmaceutical formulations for sustained drug delivery
US5968895A (en) 1996-12-11 1999-10-19 Praecis Pharmaceuticals, Inc. Pharmaceutical formulations for sustained drug delivery
AU752415B2 (en) * 1998-04-23 2002-09-19 Zentaris Ivf Gmbh Method for the treatment of fertility disorders
CO5160256A1 (es) * 1999-02-08 2002-05-30 Zentaris Ag Sales de peptidos farmaceuticamente activos para la liberacion sostenida y proceso de produccion
DE10024451A1 (de) * 2000-05-18 2001-11-29 Asta Medica Ag Pharmazeutische Darreichungsform für Peptide, Verfahren zu deren Herstellung und Verwendung
US7037889B2 (en) 2000-09-13 2006-05-02 Praecis Pharmaceuticals Inc. Pharmaceutical compositions for sustained drug delivery
US20020169125A1 (en) * 2001-03-21 2002-11-14 Cell Therapeutics, Inc. Recombinant production of polyanionic polymers and uses thereof
WO2003005889A2 (en) * 2001-07-10 2003-01-23 Ams Research Corporation Surgical kit for treating prostate tissue
US7214662B2 (en) 2001-11-27 2007-05-08 Zentaris Gmbh Injectable solution of an LHRH antagonist
US8093207B2 (en) * 2005-12-09 2012-01-10 Unigene Laboratories, Inc. Fast-acting oral peptide pharmaceutical products
EP2099375B1 (en) 2007-01-02 2014-09-24 AquaBeam LLC Minimally invasive devices for the treatment of prostate diseases
US9232959B2 (en) 2007-01-02 2016-01-12 Aquabeam, Llc Multi fluid tissue resection methods and devices
JP5506702B2 (ja) 2008-03-06 2014-05-28 アクアビーム エルエルシー 流体流れ内を伝達される光学エネルギーによる組織切除および焼灼
US9848904B2 (en) 2009-03-06 2017-12-26 Procept Biorobotics Corporation Tissue resection and treatment with shedding pulses
WO2010110455A1 (ja) * 2009-03-27 2010-09-30 国立大学法人 鹿児島大学 疎水化ポリアミノ酸からなるポリイオンコンプレックスとその用途
JP6080872B2 (ja) 2012-02-29 2017-02-15 プロセプト バイオロボティクス コーポレイション 自動化された画像誘導組織切除および治療
CN105431096B (zh) 2013-02-14 2018-07-31 普罗赛普特生物机器人公司 液体消融液体束眼外科手术的方法和装置
CN109965976B (zh) 2013-09-06 2022-05-31 普罗赛普特生物机器人公司 利用致脱脉冲的用于消融组织的装置
BR112016031037B1 (pt) 2014-06-30 2023-02-07 Procept Biorobotics Corporation Aparelho para ablação de tecido vascular
BR112017004431B1 (pt) 2014-09-05 2022-11-01 Procept Biorobotics Corporation Aparelho para tratar um paciente

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE257197C (zh) *
US4341767A (en) * 1980-10-06 1982-07-27 Syntex Inc. Nonapeptide and decapeptide analogs of LHRH, useful as LHRH antagonists
DD257197A1 (de) * 1987-01-28 1988-06-08 Univ Dresden Tech Verfahren zur herstellung von immobilisierten, in ihrer biologischen aktivitaet stabilisierten und in ihren pharmakologischen eigenschaften modifizierten insulinpraeparationen
US4801577A (en) * 1987-02-05 1989-01-31 Syntex (U.S.A.) Inc. Nonapeptide and decapeptide analogs of LHRH useful as LHRH antagonists
DD269785A1 (de) * 1988-02-08 1989-07-12 Univ Dresden Tech Verfahren zur herstellung von aktivitaetsstabilisierten und in ihren pharmakologischen eigenschaften modifizierten peptidderivaten
DD273980B5 (de) * 1988-07-12 1994-04-14 Berlin Chemie Ag Verfahren zur Herstellung von Insulin-Pr{paraten zur rektalen Anwendung
ES2081384T3 (es) * 1990-04-25 1996-03-01 Hoechst Ag Preparado farmaceutico que contiene complejos de polielectrolitos en forma de microparticulas y por lo menos una sustancia activa.
DD299265A5 (de) * 1990-09-11 1992-04-09 Technische Universitaet Dresden,De Verfahren zur herstellung von immobilisierten und aktivitaetsstabilisierten praeparaten des gonadotropin-releasing-hormons oder dessen analoga mit polyaminosaeuren
US5834520A (en) * 1992-10-08 1998-11-10 Asta-Medica Aktiengesellschaft Container for injectable mesna solutions
EP0670728A4 (en) * 1992-11-12 1996-04-17 Molecular Dynamics Inc PIPTIDE-BASED LIPOPHILE-BASED CARRIERS FOR TARGETED MEDICINE ADMINISTRATION USING A RATIONAL MEDICINE-BINDING DESIGN.
DE4305225A1 (de) * 1993-02-19 1994-08-25 Asta Medica Ag Neues Herstellverfahren für Cetrorelix Lyophilisat
US5449720A (en) * 1993-05-24 1995-09-12 Biotech Australia Pty Limited Amplification of the VB12 uptake system using polymers
US5502035A (en) * 1993-08-06 1996-03-26 Tap Holdings Inc. N-terminus modified analogs of LHRH
CA2178592C (en) * 1993-12-09 2009-07-28 Jurgen Engel Long-acting injection suspensions and a process for their preparation
US5821230A (en) * 1997-04-11 1998-10-13 Ferring Bv GnRH antagonist decapeptides

Also Published As

Publication number Publication date
NZ337343A (en) 2001-10-26
IL131181A0 (en) 2001-01-28
US6022860A (en) 2000-02-08
AU6920798A (en) 1998-10-20
NO994665L (no) 1999-09-24
EP0981377A1 (de) 2000-03-01
DK0981377T3 (da) 2003-11-10
RU2207151C2 (ru) 2003-06-27
US6054555A (en) 2000-04-25
UA69381C2 (uk) 2004-09-15
CN1249691A (zh) 2000-04-05
BR9807887B1 (pt) 2010-05-18
NO994665D0 (no) 1999-09-24
TW520288B (en) 2003-02-11
ZA982225B (en) 1998-04-03
DE19712718C2 (de) 1999-09-23
CA2285054C (en) 2007-08-21
PL190090B1 (pl) 2005-10-31
TR199902168T2 (xx) 1999-12-21
DE19712718A1 (de) 1998-10-01
DE59809575D1 (de) 2003-10-16
HUP0002059A3 (en) 2001-02-28
BR9807887A (pt) 2000-02-22
CZ337199A3 (cs) 2000-03-15
NO327404B1 (no) 2009-06-22
JP2001520662A (ja) 2001-10-30
IL131181A (en) 2004-09-27
AR012186A1 (es) 2000-09-27
AU747808B2 (en) 2002-05-23
CZ300755B6 (cs) 2009-08-05
WO1998042381A1 (de) 1998-10-01
CN1150943C (zh) 2004-05-26
HUP0002059A2 (hu) 2000-10-28
SK131699A3 (en) 2000-05-16
PL335830A1 (en) 2000-05-22
ES2206912T3 (es) 2004-05-16
JP4180120B2 (ja) 2008-11-12
HK1025255A1 (en) 2000-11-10
ATE249245T1 (de) 2003-09-15
CA2285054A1 (en) 1998-10-01
PT981377E (pt) 2004-02-27
EP0981377B1 (de) 2003-09-10

Similar Documents

Publication Publication Date Title
SK284461B6 (sk) Imobilizované komplexy antagonistov LHRH so stabilizovanou aktivitou, spôsob ich výroby a liečivo obsahujúce tento komplex
US7048947B2 (en) Sustained-release preparation
AU758596B2 (en) Sustained release compositions, process for producing the same and utilization thereof
SK74495A3 (en) Ionic molecular conjugates of biodegradable polyesters with bioactive polypeptides and a method of preparation thereof
US20090269414A1 (en) Process of preparing microspheres for sustained release having improved dispersibility and syringeability
KR20020001724A (ko) 생분해성 폴리에스테르 및 생물활성 폴리펩타이드의이온성 분자 공액체
RU2239457C2 (ru) Фармацевтическая композиция пролонгированного действия и способ ее получения
MXPA99007545A (en) Immobilized activity stabilized lhrh antagonist complexes, method for the production thereof

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20100311